Wellfully Limited announced that the Swisswell Knee PatchTM has been successfully registered as a medical device in Australia, effective August 2nd, 2022. The Swisswell Knee Patch has been registered with the TGA as a medical
device in Australia The Australian topical pain relief market is valued at USD 725 million. Registration as a medical device enables substantiated medical claims to be made, significantly broadening roll-out opportunities beyond just pharmacy partners across Australia. The Swisswell Knee PatchTM was first test-launched in August 2021, but only sold through the Company's DTC (direct-to-consumer) channels as an unregistered medical device without any medical claims. Initial feedback from consumers, as well as interest from potential distribution partners, has been most positive. With this registration, Wellfully is now able to freely engage with retail partners and
specialist distributors in the Australian market, enabling a broad scale marketing effort that can include substantiated medical claims.